OxDX validating 'deep learning' technology that identifies diseases ‘while you wait’ 15-Feb-2022 By Jane Byrne OxDX has raised £2.6m (US$3.5m) in pre-seed funding to develop AI powered rapid diagnostic technology.
UK biotech and University of Birmingham in licensing deal for nasal spray targeting COVID-19 09-Nov-2021 By Jane Byrne Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19.